In Vitro Activities of 28 Antimicrobial Agents against Staphylococcus aureus Isolates from Tertiary-Care Hospitals in Korea: a Nationwide Survey
Open Access
- 1 April 2004
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (4), 1124-1127
- https://doi.org/10.1128/aac.48.4.1124-1127.2004
Abstract
Staphylococcus aureus , one of the most frequently isolated pathogens in both hospitals and the community, has been particularly efficient at developing resistance to antimicrobial agents. As methicillin-resistant S. aureus (MRSA) has prevailed and, furthermore, as S. aureus with reduced susceptibility to vancomycin has emerged, the therapeutic options for the treatment of S. aureus infections have become limited. To update the current status of antibiotic resistance, clinical S. aureus isolates were collected from eight university-affiliated hospitals from June 1999 to January 2001. Susceptibility tests with 28 antibiotics were performed by the disk diffusion method. Among a total of 682 isolates, the methicillin resistance rate was 64% (439 of 682), and most of the MRSA isolates were resistant to multiple classes of antibiotics. Although a constitutive macrolide-lincosamide-streptogramin B resistance phenotype was common, no isolates were resistant to quinupristin-dalfopristin or linezolid. Rifampin, fusidic acid, trimethoprim-sulfamethoxazole, and arbekacin showed superior in vitro activity compared with the other antibiotics against the MRSA isolates. No isolates showed reduced susceptibility to vancomycin.Keywords
This publication has 29 references indexed in Scilit:
- Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in KoreaJournal of Clinical Microbiology, 2003
- The Prevalence and Mechanisms of Vancomycin Resistance in Staphylococcus AureusAnnual Review of Microbiology, 2002
- Epidemiology and Susceptibility of 3,051 Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY StudyJournal of Clinical Microbiology, 2001
- Patterns of Multidrug Resistance among Methicillin-Resistant Hospital Isolates of Coagulase-Positive and Coagulase-Negative Staphylococci Collected in the International Multicenter Study RESIST in 1997 and 1998Microbial Drug Resistance, 2000
- Susceptibility of 302 Methicillin-Resistant Staphylococcus aureus Isolates from 20 European University Hospitals to Vancomycin and Alternative Antistaphylococcal CompoundsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)Diagnostic Microbiology and Infectious Disease, 1999
- Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance programDiagnostic Microbiology and Infectious Disease, 1999
- Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)Diagnostic Microbiology and Infectious Disease, 1998
- Mechanisms of Methicillin Resistance in Staphylcoccus aureus and Methods for Laboratory DetectionInfection Control & Hospital Epidemiology, 1991
- To-day's DrugsBMJ, 1961